NVO
Novo Nordisk A/s
Pharmaceutical company specializing in diabetes care, obesity treatments, hemophilia management, and other biopharmaceutical products
ADRUnderlying: NVOCUSIP: K72807140HealthcareDK1 holder
American Depositary Receipt (ADR) representing Class B Common Stock
Total Value
$161.07M
Total Shares
2.32M
Net Share Change
+2.32M
Activity
1 buying
Investor
Value
Shares
Weight
Change
Causeway International Value Fund
$161.07M2.32M sharesNEW